Apoptosis Inducers
Apoptosis, a programmed cell death to eliminate damaged or abnormal cells, is a highly organized physiological process characterized by condensation of nuclear heterochromatin, cell shrinkage and loss of positional organization of organelles in the cytoplasm. Apoptosis inducers are a collection of compounds that are capable of inducing apoptosis in cells. Apoptosis has been extensively studied in numerous researches, where induction of apoptosis has been associated with a variety of events, including activation of p53 gene, transcription factor NF-κB or caspases. Apoptosis inducers have the potential to be incorporated into the management and therapy or prevention of cancer for their ability to induce apoptosis in cancer cells.
-
A4234 TW-371 CitationTarget: Bcl-2|Bcl-xl|Mcl-1Summary: Bcl-2 inhibitor, inhibits Bcl-2,Bcl-XL and Mcl-1
-
A3118 3,3'-DiindolylmethaneSummary: Anticancer and antineoplastic agent
-
A3218 BAM7Summary: BAX activator,direct and selective
-
A3237 Betulinic acidTarget: Aminopeptidases|Topoisomerases|HIVSummary: Anti-HIV and antitumor compound,pentacyclic triterpenoid
-
B3255 MeisoindigoSummary: Apoptosis inducer;potential agent for AML
-
A8188 Atractyloside Dipotassium Salt1 CitationTarget: AATSummary: AAT inhibitor
-
N1719 KaempferolSummary: Apoptosis inducer;antioxidant;flavonoid
-
A8176 Apicidin2 CitationTarget: Histone Deacetylases (HDACs)Summary: Potent HDAC inhibitor
-
A4447 2,3-DCPE hydrochlorideTarget: Apoptosis InducersSummary: Bcl-XL protein expression downregulator
-
A4448 Actinomycin D15 CitationSummary: RNA polymerase inhibitor